Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma
โ Scribed by Sheng-Nan Lu; Jing-Houng Wang; Shiann-Long Liu; Chao-Hung Hung; Chien-Hung Chen; Hung-Da Tung; Tsung-Ming Chen; Wu-Shiung Huang; Chuan-Mo Lee; Chia-Cheng Chen; Chi-Sin Changchien
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 273 KB
- Volume
- 107
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## ditions and in response to other treatments. (HEPATOL- There is increasing interest for the use of surrogate OGY 1996;24:820-823.) end points in the evaluation of treatments in patients with liver disease, but adequate validation is seldom Recent research in clinical epidemiology focused on th
Surveillance for hepatocellular carcinoma (HCC) in patients with cirrhosis is recommended but may not be performed. The extent and determinants of HCC surveillance are unknown. We conducted a population-based United States cohort study of patients over 65 years of age to examine use and determinants
The aim of this study was to elucidate the usefulness of measuring the fucosylation index (FI) of โฃ-fetoprotein (AFP) before the initiation of therapy as a new prognostic indicator for patients with hepatocellular carcinoma (HCC). ## METHODS. One hundred twelve patients with HCC who underwent tran